Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19

Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19

Interleukin-6 (IL-6) has been linked to several life-threatening disease processes. Developing a point-of-care testing platform for the immediate and accurate detection of IL-6 concentrations could present a valuable tool for improving clinical management in patients with IL-6-mediated diseases. Dra...

Full description

Bibliographic Details
Main Authors: Johnny Atallah, Dakota Archambault, Jeffrey D. Randall, Adam Shepro, Lauren E. Styskal, David R. Glenn, Colin B. Connolly, Katelin Katsis, Kathleen Gallagher, Musie Ghebremichael, Michael K. Mansour
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Diagnostics
Subjects:
IL-6
COVID-19
diagnostics
ICU
mechanical ventilation
Luminex
Online Access:https://www.mdpi.com/2075-4418/12/5/1164

Internet

https://www.mdpi.com/2075-4418/12/5/1164

Similar Items